Particularly in breast cancer cells, the activation of the NF-κB/IL-6/STAT3 pathway has been associated with a pro-tumoral response, by regulating downstream genes that control cell proliferation and angiogenesis [21]. Here, IL6 is linked to breast carcinoma.